Last refreshed Oct 19, 2026 | 24 journals analyzed | 37,772 papers indexed

Best journals to publish nanoparticle based drug delivery research

Nanoparticle-based drug delivery is a rapidly evolving field in biomedical research, focusing on the use of nanoscale carriers to improve the therapeutic efficacy and safety of drugs. This approach addresses challenges such as poor solubility, non-specific distribution, and rapid clearance of conventional therapeutics. By engineering nanoparticles with tailored properties—size, surface charge, and targeting ligands—researchers aim to enhance drug accumulation at disease sites while minimizing systemic toxicity. The field encompasses diverse materials, including liposomes, polymeric nanoparticles, dendrimers, and inorganic carriers, each offering unique advantages for controlled release and targeted delivery. Applications span cancer therapy, infectious diseases, and regenerative medicine. The analysis of 24 journals and 712 indexed papers provides a comprehensive overview of current research trends, publication venues, and impact metrics, aiding researchers in identifying suitable outlets for their work.

Submission shortlist
10
ranked journals with metric score matches
Free preview · no sign-in

Which of these journals fit your manuscript?

Paste your title and we rank 24 journals for nanoparticle based drug delivery by how much their published topics overlap with it. Your title stays in your browser and is not sent anywhere.

Want journals ranked across the whole database with fit reasons, risks and a submission strategy? See a sample AI report.

Top journals for this topic

Ranked by topic paper volume first, then matched Journal Metrics Score.

#6
Biomaterials
ISSN: 0142-9612Source: Biomaterials
Score11.2
QuartileQ1
Topic papers36
OANo
APC$4,740
#8
Pharmaceutics
ISSN: 1999-4923Source: Pharmaceutics
Score7.1
QuartileQ1
Topic papers33
OAYes
APC$3,499

Recent representative papers

Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation.

Signal transduction and targeted therapy | Score 48.6 | Q1 | 2026 Sep 01

PubMed

Peptide-targeted cubosome and hexosome nanoassemblies mitigate mitochondrial dysfunction in a MitoPark model.

Signal transduction and targeted therapy | Score 48.6 | Q1 | 2026 Aug 04

PubMed

New approach methodologies in nanomedicine: bridging the gap between in silico , in vitro , and in vivo systems.

Chemical Society reviews | Score 41.0 | Q1 | 2026 Oct 15

PubMed

Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics.

Chemical Society reviews | Score 41.0 | Q1 | 2026 Jun 22

PubMed

Tumor microenvironment-specific nanomedicine: from biology-driven to multi-omics-guided precision engineering.

Journal of hematology & oncology | Score 31.9 | Q1 | 2026 Jun 10

PubMed

Top contributing institutions

High-confidence ROR-mapped institutions from this cached PubMed topic.

Institution research map
Map points come from primary affiliations in the latest 100 papers; broader PubMed distribution uses the latest 2,000 records.
59
mapped
16
countries
100
map parsed
27
pending
64%
cache
Institution density
Primary affiliation map
latest 100 papers
Signal densitylow to high
localregionalstrongleader
Selected institution

China Pharmaceutical University

Nanjing, China
Papers
2
Mentions
2
Avg Score
5.75
Confidence
100%
Signal leaders
View ROR record

Related topic journal pages

moyamoya disease
0 shared journals | 1 shared institutions

Need the research overview?

This page is for submission decisions. The sibling PubMed overview focuses on research trends, maps, and article-level metrics.

See research overview

Get new nanoparticle based drug delivery papers by email

One email a day when PubMed adds new records for this topic. Free with an account.